Guidelines on the diagnosis and treatment of active Charcot neuro‐osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)

DK Wukich, NC Schaper, C Gooday… - Diabetes/Metabolism …, 2024 - Wiley Online Library
Abstract The International Working Group on the Diabetic Foot (IWGDF) has published
evidence‐based guidelines on the prevention and management of diabetic foot disease …

An overview of Charcot's neuroarthropathy

D Dardari - Journal of Clinical & Translational Endocrinology, 2020 - Elsevier
Charcot's neuroarthropathy is a destructive complication of the joints, which is often found in
people with diabetes with peripheral neuropathy. Despite the fact that its description was …

Diagnosis and treatment of active charcot neuro‐osteoarthropathy in persons with diabetes mellitus: a systematic review

KM Raspovic, NC Schaper, C Gooday… - Diabetes/Metabolism …, 2024 - Wiley Online Library
Background There are uncertainties regarding the diagnostic criteria, optimal treatment
methods, interventions, monitoring and determination of remission of Charcot neuro …

RANKL-RANK-OPG pathway in charcot diabetic foot: pathophysiology and clinical-therapeutic implications

T Greco, A Mascio, C Comisi, C Polichetti… - International Journal of …, 2023 - mdpi.com
Charcot Foot (CF), part of a broader condition known as Charcot Neuro-Osteoarthropathy
(CNO), is characterized by neuropathic arthropathy with a progressive alteration of the foot …

RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus

V Kumar, S Agarwal, B Saboo, B Makkar - International journal of diabetes …, 2022 - Springer
Hypertension and diabetes mellitus (DM) are two of the leading lifestyle diseases in the
Indian and South Asian populations that often co-exist due to overlap** …

Effect of recombinant human parathyroid hormone (1-84) on resolution of active Charcot neuro-osteoarthropathy in diabetes: a randomized, double-blind, placebo …

NL Petrova, NK Donaldson, M Bates, W Tang… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE Fractures in Charcot neuro-osteoarthropathy (CN) often fail to heal despite
prolonged immobilization with below-knee casting. The aim of the study was to assess the …

Nonoperative treatment of Charcot neuro-osteoarthropathy

FWA Waibel, T Böni - Foot and Ankle Clinics, 2022 - foot.theclinics.com
Charcot neuro-osteoarthropathy (CN) has been described more than two and a half
centuries ago. 1 Until today, the pathophysiology is not fully understood. 2 Presence of …

Efficacy of medical treatment for Charcot neuroarthropathy: a systematic review and meta-analysis of randomized controlled trials

A Rastogi, A Bhansali, EB Jude - Acta Diabetologica, 2021 - Springer
No pharmacotherapeutic agents are yet recommended for active CN though many anti-
resorptive agents have been studied. We conducted a systematic review and meta-analysis …

Anti-RANKL antibody for active Charcot foot neuro-osteoarthropathy in patients with diabetes and chronic kidney disease

A Rastogi, R Singh, J Ghosh… - Foot & Ankle …, 2024 - journals.sagepub.com
Background: Charcot neuroosteoarthropathy (CNO) is characterized with increased
osteoclastic activity that can be curbed with antiresorptive agents. Chronic kidney disease …

Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysis

PW Chen, HY Su, YK Tu, CH Wu, JI Yeh… - Osteoporosis …, 2023 - Springer
Previous evidence suggests that bisphosphonates may improve glycemic control. The
present meta-analysis, comprising seven studies with 1,233,844 participants, demonstrated …